Daniel K. Podolsky, M.D., of University of Texas Southwestern Medical Center, to Join Agilent Technologies Board of Directors
18 Marzo 2015 - 2:05PM
Business Wire
Agilent Technologies Inc. (NYSE: A) today announced that
Daniel K. Podolsky, M.D., president of the University of Texas
Southwestern Medical Center, has been appointed to the company’s
board of directors, effective in July. Dr. Podolsky’s appointment
increases Agilent’s board to 10 members.
“We are very pleased to welcome Dr. Podolsky to the Agilent
board of directors,” said James G. Cullen, Agilent chairman. “He is
an excellent addition at an important time in the company’s growth.
Dr. Podolsky has a depth of knowledge from his many years as a
leader in the medical field, as well as a practical business sense
as president of a top medical center. His insights into health care
delivery issues are particularly relevant as Agilent continues its
growth in the life science solutions and diagnostics markets.”
UT Southwestern Medical Center in Dallas is a leading academic
medical center, patient care provider and research institution. Dr.
Podolsky has served as its president since 2008.
He was previously chief academic officer and faculty dean,
Academic Programs, for Partners Health System, Inc., a Boston-based
nonprofit health care system committed to patient care, research,
teaching and service. He also served concurrently as the
Mallinckrodt Professor of Medicine at Harvard Medical School and
the Chief of Gastroenterology at Massachusetts General
Hospital.
“I am honored to be joining the Agilent board of directors,” Dr.
Podolsky said. “The company has long been known for the quality of
its products and people, and is now at a pivotal point in
leveraging its experience into new and growing medical-related
markets. I look forward to supporting its growth and success.”
Dr. Podolsky holds the Philip O’Bryan Montgomery, Jr., M.D.,
Distinguished Presidential Chair in Academic Administration, and
the Doris and Bryan Wildenthal Distinguished Chair in Medical
Science at the University of Texas Southwestern Medical Center. He
is a member of the Institute of Medicine of the U.S. National
Academy of Sciences; the board of the Southwestern Medical
Foundation; and the Scientific Advisory Board of Antibe
Therapeutics, Inc., a company focused on the treatment of diseases
characterized by inflammation, pain and/or vascular dysfunction.
Dr. Podolsky is also a member of the National Academies of Sciences
Board on Army Science and Technology, and he serves on the board of
directors of the pharmaceutical company GlaxoSmithKline.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in
life sciences, diagnostics and applied chemical markets, is the
premier laboratory partner for a better world. Agilent works with
customers in more than 100 countries, providing instruments,
software, services and consumables for the entire laboratory
workflow. Agilent generated revenues of $4.0 billion in fiscal
2014. The company employs about 12,000 people worldwide.
Information about Agilent is available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and
executive news is available at www.agilent.com/go/news.
EDITORIAL CONTACT:Agilent Technologies Inc.Michele Drake,
+1-408-345-8396michele_drake@agilent.comINVESTOR CONTACT:Alicia
Rodriguez,+1-408-345-8948alicia_rodriguez@agilent.com
American Oil & Gas Common Stock (NYSE:AEZ)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
American Oil & Gas Common Stock (NYSE:AEZ)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024